A citation-based method for searching scientific literature

Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
Times Cited: 240



Peter D Beitsch, Pat W Whitworth, Kevin Hughes, Rakesh Patel, Barry Rosen, Gia Compagnoni, Paul Baron, Rache Simmons, Linda Ann Smith, Ian Grady, Michael Kinney, Cynara Coomer, Karen Barbosa, Dennis R Holmes, Eric Brown, Linsey Gold, Patricia Clark, Lee Riley, Samuel Lyons, Antonio Ruiz, Sadia Kahn, Heather MacDonald, Lisa Curcio, Mary Kay Hardwick, Shan Yang, Ed D Esplin, Robert L Nussbaum. J Clin Oncol 2019
Times Cited: 110




List of shared articles



Times cited

Frequency and spectrum of mutations across 94 cancer predisposition genes in African American women with invasive breast cancer.
Leann A Lovejoy, Seth K Rummel, Clesson E Turner, Craig D Shriver, Rachel E Ellsworth. Fam Cancer 2021
0

Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients.
Vanessa Lattimore, Michael T Parsons, Amanda B Spurdle, John Pearson, Klaus Lehnert, Jan Sullivan, Caroline Lintott, Suzannah Bawden, Helen Morrin, Bridget Robinson,[...]. Breast Cancer Res Treat 2021
0

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.
N Jewel Samadder, Douglas Riegert-Johnson, Lisa Boardman, Deborah Rhodes, Myra Wick, Scott Okuno, Katie L Kunze, Michael Golafshar, Pedro L S Uson, Luke Mountjoy,[...]. JAMA Oncol 2021
21


Increased ease of access to genetic counseling for low-income women with breast cancer using a point of care screening tool.
Smita K Rao, Kimberly A Thomas, Rajbir Singh, Eden Biltibo, Philip E Lammers, Georgia L Wiesner. J Community Genet 2021
0


Economic impact of multigene panel testing for hereditary breast and ovarian cancer.
Stacey Dacosta Byfield, Helen Wei, Mary DuCharme, Johnathan M Lancaster. J Comp Eff Res 2021
0

Outcomes of large panel genetic evaluation of breast cancer patients in a community-based cancer institute.
Alexis K Bagwell, Thomas L Sutton, Stuart Gardiner, Nathalie Johnson. Am J Surg 2021
0

Prevalence and Clinicopathological Characteristics of Moderate and High-Penetrance Genes in Non-BRCA1/2 Breast Cancer High-Risk Spanish Families.
Maria Fonfria, Inmaculada de Juan Jiménez, Isabel Tena, Isabel Chirivella, Paula Richart-Aznar, Angel Segura, Ana Beatriz Sánchez-Heras, Eduardo Martinez-Dueñas. J Pers Med 2021
0

Mutational profile of hereditary breast and ovarian cancer - Establishing genetic testing guidelines in a developing country.
Ana Krivokuca, Milica Mihajlovic, Snezana Susnjar, Ivana Bozovic Spasojevic, Ivana Minic, Lazar Popovic, Mirjana Brankovic-Magic. Curr Probl Cancer 2021
0

Rate of BRCA mutation in patients tested under NCCN genetic testing criteria.
Anna C Beck, Haimiao Yuan, Junlin Liao, Pamela Imperiale, Krysten Shipley, Lillian M Erdahl, Sonia L Sugg, Ronald J Weigel, Ingrid M Lizarraga. Am J Surg 2020
6

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.
Siddhartha Yadav, Chunling Hu, Steven N Hart, Nicholas Boddicker, Eric C Polley, Jie Na, Rohan Gnanaolivu, Kun Y Lee, Tricia Lindstrom, Sebastian Armasu,[...]. J Clin Oncol 2020
13

Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.
Ranjit Manchanda, Sari Lieberman, Faiza Gaba, Amnon Lahad, Ephrat Levy-Lahad. Annu Rev Genomics Hum Genet 2020
10

Predictors of genetic testing uptake in newly diagnosed breast cancer patients.
Mary K Ladd, Beth N Peshkin, Claudine Isaacs, Gillian Hooker, Shawna Willey, Heiddis Valdimarsdottir, Tiffani DeMarco, Suzanne O'Neill, Savannah Binion, Marc D Schwartz. J Surg Oncol 2020
0

Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome.
Tomoko Kaneyasu, Seiichi Mori, Hideko Yamauchi, Shozo Ohsumi, Shinji Ohno, Daisuke Aoki, Shinichi Baba, Junko Kawano, Yoshio Miki, Naomichi Matsumoto,[...]. NPJ Breast Cancer 2020
5


Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome.
Tomoko Kaneyasu, Seiichi Mori, Hideko Yamauchi, Shozo Ohsumi, Shinji Ohno, Daisuke Aoki, Shinichi Baba, Junko Kawano, Yoshio Miki, Naomichi Matsumoto,[...]. NPJ Breast Cancer 2020
1